CA2091651C - Agent for suppresion and interception of mailard reaction - Google Patents

Agent for suppresion and interception of mailard reaction Download PDF

Info

Publication number
CA2091651C
CA2091651C CA002091651A CA2091651A CA2091651C CA 2091651 C CA2091651 C CA 2091651C CA 002091651 A CA002091651 A CA 002091651A CA 2091651 A CA2091651 A CA 2091651A CA 2091651 C CA2091651 C CA 2091651C
Authority
CA
Canada
Prior art keywords
agent
group
compound
formula
organogermanium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002091651A
Other languages
English (en)
French (fr)
Other versions
CA2091651A1 (en
Inventor
Norihiro Kakimoto
Kunie Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asai Germanium Research Institute
Original Assignee
Asai Germanium Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asai Germanium Research Institute filed Critical Asai Germanium Research Institute
Publication of CA2091651A1 publication Critical patent/CA2091651A1/en
Application granted granted Critical
Publication of CA2091651C publication Critical patent/CA2091651C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/30—Germanium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002091651A 1992-03-16 1993-03-15 Agent for suppresion and interception of mailard reaction Expired - Lifetime CA2091651C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4091685A JPH05255130A (ja) 1992-03-16 1992-03-16 メイラード反応抑制改善剤
JP04-091685 1992-03-16

Publications (2)

Publication Number Publication Date
CA2091651A1 CA2091651A1 (en) 1993-09-17
CA2091651C true CA2091651C (en) 2003-09-23

Family

ID=14033361

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091651A Expired - Lifetime CA2091651C (en) 1992-03-16 1993-03-15 Agent for suppresion and interception of mailard reaction

Country Status (11)

Country Link
US (1) US5352815A (enExample)
JP (1) JPH05255130A (enExample)
KR (1) KR100245571B1 (enExample)
AU (1) AU659589B2 (enExample)
CA (1) CA2091651C (enExample)
CH (1) CH685876A5 (enExample)
DE (1) DE4308374C2 (enExample)
FR (1) FR2689763B1 (enExample)
GB (1) GB2265547B (enExample)
IT (1) IT1271438B (enExample)
TW (1) TW278036B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1143432A (ja) * 1997-07-25 1999-02-16 Biremo Sci:Kk 脳の老化抑制及び治療剤
CA2339879C (en) 1998-08-24 2011-11-15 Toshio Miyata Carbonyl-stress improving agent and peritoneal dialysate

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA970277A (en) * 1972-05-25 1975-07-01 Kazuhiko Asai Organo germanium sesquioxide composition for treating hypertension or hypotonia
JPS5632485A (en) * 1979-08-24 1981-04-01 Pola Chem Ind Inc Preparation of organogermanium compound
DE3212817A1 (de) * 1982-04-06 1983-10-13 Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya Pharmazeutisch wirksame organische germaniumverbindungen und verfahren zu deren herstellung
JPS601317B2 (ja) * 1982-08-23 1985-01-14 紀博 柿本 親水性及び親油性を併せ有する有機ゲルマニウム化合物
JPS6041472A (ja) * 1983-08-16 1985-03-05 Refuorumu Syst Kk 美容・健康飲料
JPS60226592A (ja) * 1984-04-25 1985-11-11 Asai Gerumaniumu Kenkyusho:Kk 抗酸化剤
JPS61145115A (ja) * 1984-12-18 1986-07-02 Asai Gerumaniumu Kenkyusho:Kk 塵肺症患者用風邪症候群予防剤
JPS63107920A (ja) * 1986-06-18 1988-05-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
US4973553A (en) * 1987-09-09 1990-11-27 Asai Germanium Research Institute Salt or organogermanium compound and medicine containing the same
CA1314210C (en) * 1987-10-29 1993-03-09 Norihiro Kakimoto Agent for improving reduced functions of organs caused by inhibited blood circulation
JP2698870B2 (ja) * 1987-10-29 1998-01-19 株式会社浅井ゲルマニウム研究所 シクロスポリンの投与による腎毒性の軽減剤
JPH01149723A (ja) * 1987-12-07 1989-06-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
JP2652556B2 (ja) * 1988-08-29 1997-09-10 株式会社浅井ゲルマニウム研究所 有機ゲルマニウム化合物及びその製造方法
US5008416A (en) * 1989-06-20 1991-04-16 Sanwa Kagaku Kenkyusho Co., Ltd. Organogermanium compound, process for the preparation of same as well as use thereof
AU635045B2 (en) * 1989-07-20 1993-03-11 Asai Germanium Research Institute Co., Ltd Agent for preventing and treating opacity of lens
JPH03251526A (ja) * 1990-02-28 1991-11-11 Sanwa Kagaku Kenkyusho Co Ltd 糖尿病依存型自己免疫疾患治療、予防用薬剤

Also Published As

Publication number Publication date
TW278036B (enExample) 1996-06-11
GB2265547A (en) 1993-10-06
AU659589B2 (en) 1995-05-18
US5352815A (en) 1994-10-04
DE4308374C2 (de) 2002-01-03
FR2689763A1 (fr) 1993-10-15
CH685876A5 (fr) 1995-10-31
FR2689763B1 (fr) 1995-04-28
JPH05255130A (ja) 1993-10-05
DE4308374A1 (de) 1993-10-07
ITMI930491A1 (it) 1994-09-15
KR100245571B1 (ko) 2000-03-02
ITMI930491A0 (it) 1993-03-15
GB9305309D0 (en) 1993-05-05
AU3511893A (en) 1993-09-23
IT1271438B (it) 1997-05-28
CA2091651A1 (en) 1993-09-17
KR930019210A (ko) 1993-10-18
GB2265547B (en) 1996-07-31

Similar Documents

Publication Publication Date Title
Wawzonek et al. Epiphyseal plate lesions, degenerative arthritis, and dissecting aneurysm of the aorta produced by aminonitriles
Hughes On the metabolic fate of isoniazid
CA2029420C (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
Goodman Vitamin A transport and retinol-binding protein metabolism
US6329361B1 (en) High-dose chromic picolinate treatment of type II diabetes
JP2001523663A (ja) 進歩した糖化最終生成物中間体及び後−アマドリ阻害
JP2002526379A (ja) インシュリン活性を増強する組成物およびその方法
NL8701631A (nl) Werkwijzen voor het bereiden van een farmaceutisch preparaat en voor het behandelen van bepaalde ziekten daarmede.
EP0325936A2 (en) Aminoguanidine derivatives and inhibitory agents on maillard reaction containing them as active ingredients
JPS63270626A (ja) 抗潰瘍剤
US5352815A (en) Agent for suppression and interception of mailard reaction
GOMMORI et al. Effect of ginseng saponins on cholesterol metabolism. II. Effect of ginsenosides on cholesterol synthesis by liver slice
US4919917A (en) Agent for reducing nephrotoxicity caused by cyclosporin administration
Tyor et al. Effect of Pre-Feeding of Fat on I131 Triolein Absorption in Subtotal Gastrectomy Patients
Nakamura et al. Prevention and reversible solubilization of advanced glycation and products (AGE) by organic germanium compounds as derivatives of amino acids
EP0661295B1 (en) Cedar pollen protein and uses thereof
JP4178584B2 (ja) 抗アレルギー剤
US4737521A (en) Suramin sodium for use as an immunostimulant
US5338850A (en) Pyridinium derivatives
JPH07506568A (ja) 糖尿病治療のための既存の薬剤の使用
US6001875A (en) In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation
JPH1135494A (ja) 糖尿病又は腎不全に伴う合併症の診断試薬
CA1270762A (fr) Compositions pharmaceutiques renfermant un derive de l'acide maleopimarique
US5350766A (en) Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
JP2001226263A (ja) 肥満予防剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130315

MKEC Expiry (correction)

Effective date: 20131009